Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia
David W. Crabb, Ramon A. Bataller, Naga Chalasani et al. · Gastroenterology · 2016
Cited by 553 works. doi:10.1053/j.gastro.2016.02.042
Authors
- David W. Crabb
- Ramon A. Bataller
- Naga Chalasani
- Patrick S. Kamath
- Michael Ronan Lucey
- Philippe Mathurin
- Craig James McClain
- Arthur J. McCullough
- Mack C. Mitchell
- Timothy R.M. Morgan
- Laura E. Nagy
- Svetlana Radaeva
- Arun Jayant Sanyal
- Vijay H. Shah
- Gyöngyi Szabó
References
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
- Alcohol-Induced Hepatic Injury in Nonalcoholic Volunteers
- Excess Weight Risk Factor for Alcoholic Liver Disease
- Methylprednisolone Therapy in Patients with Severe Alcoholic Hepatitis
- Alcoholic Hepatitis
- Prednisolone or Pentoxifylline for Alcoholic Hepatitis
- Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis
- Prognostic factors in alcoholic liver disease. VA Cooperative Study Group.
- Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience
- Alcoholic liver disease: mechanisms of injury and targeted treatment